Table 2.
Adherence to Quality Indicators
| Measure | Overall | By Practice (No. yes/No. total) | Fisher's Exact Test P | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | ||||||||
| % | No.Yes/No. Total | % | No. Yes/No. Total | % | No. Yes/No. Total | % | No. Yes/No. Total | % | No. Yes/No. Total | ||
| Path report confirming malignancy | 93 | 243/260 | 96 | 98/102 | 95 | 58/61 | 94 | 48/51 | 85 | 39/46 | .10 |
| Dukes or AJCC staging | 90 | 234/260 | 86 | 88/102 | 93 | 57/61 | 94 | 48/51 | 89 | 41/46 | .37 |
| CEA before surgery or chemotherapy | 57 | 149/260 | 59 | 60/102 | 48 | 29/61 | 57 | 29/51 | 67 | 31/46 | .23 |
| CEA in 6 months after surgery or chemotherapy | 83 | 215/260 | 84 | 86/102 | 82 | 50/61 | 75 | 38/51 | 89 | 41/46 | .28 |
| Colon evaluation within 12 months* | 46 | 71/156 | 37 | 17/46 | 47 | 22/47 | 45 | 14/31 | 56 | 18/32 | .41 |
| Chemotherapy discussed or recommended† | 96 | 190/197 | 95 | 83/87 | 92 | 36/39 | 100 | 35/35 | 100 | 36/36 | .23 |
| Chemotherapy consent documented‡ | 85 | 121/143 | 100 | 54/54 | 38 | 13/34 | 100 | 23/23 | 97 | 31/32 | < .001 |
| Chemotherapy flow sheet‡ | 98 | 140/143 | 100 | 54/54 | 97 | 33/34 | 100 | 23/23 | 94 | 30/32 | .18 |
Abbreviations: AJCC, American Joint Committee on Cancer; CEA, carcinoembryonic antigen.
* Includes only patients for whom 12 months had elapsed.
† Includes only patients for whom guidelines recommend use of chemotherapy.
‡ Includes only patients who received chemotherapy.